Koyfin Home > Directory > Health Care > Acorda Therapeutics > EBITDA Margin

Acorda Therapeutics EBITDA Margin Chart (ACOR)

Acorda Therapeutics annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Acorda Therapeutics EBITDA Margin for the quarter ending June 06, 2020 was $-42m a -14.93% increase of 6m year over year
  • Acorda Therapeutics EBITDA Margin for the last 12 months ending June 06, 2020 was $-38m a -14.16% increase of 5m year over year
  • Acorda Therapeutics Annual EBITDA Margin for 2019 was $-43m a 152.14% decrease of -65m from 2018
  • Acorda Therapeutics Annual EBITDA Margin for 2018 was $22m a -3.00% decrease of -1m from 2017
  • Acorda Therapeutics Annual EBITDA Margin for 2017 was $23m a 90.15% increase of 21m from 2016
Other Margins & Efficiency Metrics:
  • Acorda Therapeutics Return on Capital % for the quarter ending December 12, 2018 was -4.27 a 144.67% decrease of -6.18 year over year
  • Acorda Therapeutics Return on Equity % for the quarter ending December 12, 2018 was 6.34 a 196.69% increase of 12.47 year over year
View Chart On Koyfin

Quarterly ACOR EBITDA Margin Data

06/2020$-42m
03/2020$-79m
12/2019$-5m
09/2019$-48m
06/2019$-52m
03/2019$-71m
12/2018$-19m
09/2018$37m
06/2018$36m
03/2018$9m

Annual ACOR EBITDA Margin Data

2019$-43m
2018$22m
2017$23m
2016$2m
2015$12m
2014$13m
2013$11m
2012$10m
2011$18m
2010$-2m